Dolby Laboratories (DLB) EPS (Weighted Average and Diluted) (2009 - 2026)

Dolby Laboratories has reported EPS (Weighted Average and Diluted) for 18 years, with the latest figure at $0.99 in Q1 2026.

• For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 5.32% year-over-year to $0.99; the trailing twelve-month figure through Mar 2026 stood at $2.53 (down 4.17% YoY), and the FY2025 full-year result was $2.62, down 2.6% from the prior year.
• EPS (Weighted Average and Diluted) for Q1 2026 stood at $0.99, up from $0.55 in the prior quarter.
• The five-year high for EPS (Weighted Average and Diluted) was $1.01 in Q1 2024, with the low at $0.09 in Q3 2023.
• Historically, EPS (Weighted Average and Diluted) has averaged $0.59 across 5 years, with a median of $0.55 in 2025.
• Annual changes were most pronounced in 2023 — EPS (Weighted Average and Diluted) plunged 68.97% — and 2024, when it jumped 566.67%.
• Dolby Laboratories' EPS (Weighted Average and Diluted) stood at $0.82 in 2022, then fell by 15.85% to $0.69 in 2023, then gained by 1.45% to $0.7 in 2024, then slipped by 21.43% to $0.55 in 2025, then surged by 80.0% to $0.99 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.99 (Q1 2026), $0.55 (Q4 2025), and $0.51 (Q3 2025), per Business Quant data.